PURE
PURE Bioscience, Inc.
Set alert
- YTD
- +75.00%
- 1 year
- 0.00%
- Open
- 0.0711
- Prev close
- 0.08
- Mkt cap
- 9.81M
- Vol
- 10.28K
- Avg vol
- 28.85K
- EPS
- -0.02
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.065
- High
- 0.075
- Forward P/E
- 0.00
- Beta
- -1.99
- Short ratio
- 2.56
- Inst. own
- 2.50%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.02
- 200-d avg
- 1.03
- 1y target
- 0.00
Key statistics
- Market cap
- 64.82M
- Enterprise value
- 115.38M
- Trailing P/E
- -3.95
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 50.29
- Price / book
- 12.99
- EPS (TTM)
- -0.253
- Beta
- -1.99
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 1.29M
- Revenue growth
- 127.80%
- Free cash flow
- -1.07M
- Total cash
- 5.19M
- Total debt
- 0
- Return on equity
- -388.09%
- Shares outstanding
- 64.82M
- Short % of float
- 2.08%
- 50-day average
- 1.02
- 200-day average
- 1.03
Analyst view
Consensus: buy
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 16, 2024 | Oct 1, 2024 | 0.00 | -0.01 | — | — |
| Oct 29, 2024 | Jul 1, 2024 | 0.00 | -0.01 | — | — |
| Jun 14, 2024 | Apr 1, 2024 | 0.00 | -0.01 | — | — |
| Mar 18, 2024 | Jan 1, 2024 | 0.00 | -0.01 | — | — |
| Dec 14, 2023 | Oct 1, 2023 | 0.00 | -0.01 | — | — |
| Oct 30, 2023 | Jul 1, 2023 | 0.00 | -0.03 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 7, 2011 | C.K. Cooper | init | — | Buy |
About PURE Bioscience, Inc.
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a antimicrobial food processing aid for use in poultry processing and produce processing; PURE Multi-Purpose and Floor Cleaner Concentrate used to clean various resilient surfaces, including floors, glass, and food contact surfaces; PURE Multi-Purpose Hi-Foam Cleaner Concentrate used to clean stainless steel equipment, resilient floors, walls, and painted surfaces; and SILVÉRION, an antimicrobial solution used against bacteria, viruses, yeast, and molds. It sells its products to distributors and end users. PURE Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California.
- Sector
- Basic Materials
- Industry
- Chemicals - Major Diversified
- Country
- United States
- Website
- purebio.com
News
Your note
Sign in to keep a note on PURE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ELLIOTT MARK STUART | Officer | Disposition (Non Open Market) | Apr 5, 2016 | 72,350 |
| FRANCHISE BRANDS, LLC | Beneficial Owner (10% or more) | Purchase | Oct 22, 2015 | 18,666,666 |
| LAMBERT HENRY R. | Officer | Acquisition (Non Open Market) | Jul 30, 2015 | 842,857 |
| LEE TOM Y | Director | Option Exercise | May 19, 2016 | 3,899,337 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Goldman Capital Management, Inc. | 1.36% | 879,184 | 958.31K | Sep 29, 2016 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Starboard Investment Tr-SCS Tactical Allocation Fund | 0.52% | 335,026 | 304.87K | Aug 30, 2016 |
| AMG Managers Essex Small/Micro Cap Growth Fd | 0.20% | 130,148 | 136.66K | Jun 29, 2016 |